OxTalks is Changing
Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
GLP-1@Novo Nordisk: From compound innovation to clinical outcome
The room has a limit of 100 people
Lotte is a Scientific Vice President in Global Research at Novo Nordisk in Denmark. She is a chemist by training, has a doctoral degree in scientific medicine and has worked for Novo Nordisk for 30 years. She is a recognised expert of GLP-1 based drug discovery and mechanism of action studies in diabetes, obesity and toxicology. Her research focuses on drug discovery, receptor expression, molecular pharmacology, in vivo pharmacology, mechanistic toxicology and mechanism of action of drugs in obesity and diabetes, and has resulted in app. 70 peer-reviewed original papers.
Date:
9 May 2018, 14:15
Venue:
Big Data Institute (NDM), Old Road Campus OX3 7LF
Venue Details:
Seminar room 0 & 1
Speaker:
Lotte Bjerre Knudsen (Novo Nordisk A/S)
Organiser contact email address:
cepo@novonordisk.com
Part of:
Novo Nordisk Research Centre Oxford (NNRCO)
Booking required?:
Not required
Cost:
0
Audience:
Public
Editor:
Cecile Poulsen
